OGEN stock forecast
Our latest prediction for Oragenics, Inc.'s stock price was made on the Sept. 18, 2018 when the stock price was at 0.42$.
In the short term (2weeks), OGEN's stock price should outperform the market by 5.97%. During that period the price should oscillate between -11.56% and +29.88%.
In the medium term (3months), OGEN's stock price should outperform the market by 13.39%. During that period the price should oscillate between -23.31% and +74.01%.Get email alerts
Create a solid portfolio with OGEN
About Oragenics, Inc.
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.42$ per share.
The book value per share is -0.21$
Three months stock forecastSept. 18, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|